Cue Biopharma Inc buy Piper Sandler
Start price
03.04.24
/
50%
€1.66
Target price
03.04.25
€7.39
Performance (%)
-58.13%
End price
04.04.25
€0.70
Summary
This prediction ended on 04.04.25 with a price of €0.70. Massive losses of -58.13% were the result for the BUY prediction by Piper_Sandler. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cue Biopharma Inc | 161.658% | 161.658% | -26.061% |
| iShares Core DAX® | 0,79 % | 1,97 % | 13,39 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % | 39,72 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % | 49,89 % |
| iShares S&P 500 | 2,50 % | 2,76 % | 30,23 % |
Comments by Piper_Sandler for this prediction
In the thread Cue Biopharma Inc diskutieren
Cue Biopharma, Inc. (NASDAQ: CUE) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $8.00 price target on the stock.
Ratings data for CUE provided by MarketBeat
In the thread Trading Cue Biopharma Inc
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten